• Home
• Portrait
  • Health Sciences and Technologies in Luxembourg
  • Cluster Mission and Objectives
  • Cluster Management
• Activities
  • Your Needs - Our Support
  • Working groups
  • Activities 2010
• Members
  • Benefits for Members
  • Become a member
  • Members list
• Funding Opportunities
  • National Funding for Companies
  • National Funding for Public Research Organisations
  • Public-Private Partnerships
  • European Funding
  • Calls
• Business Opportunities
  • Enterprise Europe Network
  • Science Park and Bioincubator
  • Technology profiles
  • Job opportunities
• Contact

Luxembourg BioHealth Cluster

The Luxembourg BioHealth Cluster  is a young emerging Cluster aiming to reinforce and capitalise on the National Strategy developed by the Government to achieve scientific excellence in molecular diagnostics, the cornerstone of personalised medicine and to legitimise the country as a recognised and attractive territory for biomedical research, development, innovation (RDI) and business.

Our members are R&D companies, Public Research Organisations, laboratories, hospitals and other actors (patients associations, providers of capital and services…) based in Luxembourg whose activities are related to Health Sciences and Technologies. With a principal focus on molecular diagnostics, the Cluster’s umbrella also covers other RDI/business domains that are key elements in an integrated patient-based personalised medicine approach, such as new therapeutics, bioinformatics, medical device and telemedicine. Supporting this dynamic and steadily growing biocommunity is our main objective. Therefore, we provide our members with a portfolio of added-value activities and services  to support  them in their daily RDI and/or business challenges and to increase their national and international visibility and attractiveness. 

The Luxembourg BioHealth Cluster participates in Business meets Research  22 - 23 May 2012

Opportunities

• Calls
• Technology Profiles

• Innovative Medicines Initiative (IMI) 5th Call 2012
  

• A unique microporous PVC-silica support for immobilised enzymes, proteins, cells, ligands

• A microporous PVC-silica membrane with unique liquid absoprtion/desorption properties for filtration and fluid treatment/cleaning

• A high-resolution and high-sensitive technique for tissue imaging

• In vitro multi-target screening platform to identify novel CNS regenerative drugs for commercial development

News

• 
  10-05-2012 Outcomes of the Luxembourg Health Summit: initiatives to guarantee the excellence of the country's health system

  The Health Summit on 2-3 May aimed to lay the foundations for launching a new initiative and achieving a new vision: to make Luxembourg the healthiest country on earth, one person at a time.

• 
  09-05-2012 Annual Stakeholder Forum of the Innovative Medicines Initiative (IMI)

  The forum, which will take place in Brussels on 30 May, is an an excellent opportunity to learn more about the topics covered by IMI and discuss them in person with the topic coordinators.

• 
  08-05-2012 European Commission publishes orientation paper for the FP7 theme Knowledge-based bioeconomy (KBBE)

  The aim of the publication is to give potential consortia the time to prepare for the 2013 KBBE Call for proposals, which will be officially published by mid July 2012.

Events

• 
  22-05-2012 Business meets Research 2012
• 29-05-2012 EC Open Information Day & Partnering Event 2012
• 30-05-2012 Euro-Biotech Partnering Summit 2012
• 30-05-2012 IMI Stakeholder Forum
• 
  04-06-2012 European Funding Week 2012: Special information day on Health and Knowledge Based Bio-Economy (KBBE)
• 
  13-06-2012 Greater Region Business Days 2012